Suppr超能文献

CD133阳性细胞可能是人脑膜瘤细胞高效增殖的原因。

CD133-positive cells might be responsible for efficient proliferation of human meningioma cells.

作者信息

Tang Hailiang, Gong Ye, Mao Ying, Xie Qing, Zheng Mingzhe, Wang Daijun, Zhu Hongda, Wang Xuanchun, Chen Hong, Chen Xiancheng, Zhou Liangfu

机构信息

Department of Neurosurgery, Huashan Hospital, Fudan University, No.12, Middle wulumuqi road, Shanghai 200040, China.

Department of Endocrinology, Huashan Hospital, Fudan University, No.12, Middle wulumuqi road, Shanghai 200040, China.

出版信息

Int J Mol Sci. 2012;13(5):6424-6439. doi: 10.3390/ijms13056424. Epub 2012 May 23.

Abstract

Owing to lack of appropriate model systems, investigations of meningioma biology have come to a stop. In this study, we developed a comprehensive digestion method and defined a culture system. Using this method and system, primary meningioma cells in conditioned suspension medium and a hypoxic environment could be amplified in spheres and were passaged for more than ten generations. Meningioma sphere cells were positive for meningioma cell markers and negative for markers of neural cell types. Importantly, we found the cells expressed the stem cell marker, CD133, but not nestin. All of the tumor sphere cell populations showed a slower degree of cell proliferation than that of human glioma cells and fetal neural stem cells (NSCs). Further studies showed that the proliferative rate was positively correlated with CD133 expression. The higher the CD133 expression, the faster the cell proliferation. With the increase in cell generations, the cell proliferation rate gradually slowed down, and CD133 expression also decreased. Single CD133(+) cells rather than CD133(-) cells could form spheres. Thus, the results above indicated that those cells expressing CD133 in spheres might be stem-like cells, which may be responsible for efficient amplification of human meningioma cells. Decreased expression of CD133 may lead to the failure of long-term passaging.

摘要

由于缺乏合适的模型系统,脑膜瘤生物学的研究陷入了停滞。在本研究中,我们开发了一种全面的消化方法并定义了一种培养系统。使用这种方法和系统,在条件悬浮培养基和低氧环境中的原发性脑膜瘤细胞能够在球体中扩增,并传代十代以上。脑膜瘤球体细胞对脑膜瘤细胞标志物呈阳性,对神经细胞类型标志物呈阴性。重要的是,我们发现这些细胞表达干细胞标志物CD133,但不表达巢蛋白。所有肿瘤球体细胞群体的细胞增殖程度均比人胶质瘤细胞和胎儿神经干细胞(NSCs)慢。进一步研究表明,增殖率与CD133表达呈正相关。CD133表达越高,细胞增殖越快。随着细胞代数的增加,细胞增殖率逐渐减慢,CD133表达也降低。单个CD133(+)细胞而非CD133(-)细胞能够形成球体。因此,上述结果表明,球体中表达CD133的那些细胞可能是干细胞样细胞,这可能是人脑膜瘤细胞高效扩增的原因。CD133表达的降低可能导致长期传代失败。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c1a/3382801/9fa39f14f6b6/ijms-13-06424f1a.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验